AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $211.39 million. The enterprise value is $224.65 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 26.36 million shares outstanding. The number of shares has increased by 2.18% in one year.
Current Share Class | 26.36M |
Shares Outstanding | 26.36M |
Shares Change (YoY) | +2.18% |
Shares Change (QoQ) | +0.62% |
Owned by Insiders (%) | 1.60% |
Owned by Institutions (%) | 24.79% |
Float | 25.85M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.28 |
Forward PS | 2.06 |
PB Ratio | 47.68 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 10.22.
Current Ratio | 2.83 |
Quick Ratio | 2.37 |
Debt / Equity | 10.22 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.27 |
Financial Efficiency
Return on equity (ROE) is -230.96% and return on invested capital (ROIC) is -49.84%.
Return on Equity (ROE) | -230.96% |
Return on Assets (ROA) | -36.97% |
Return on Invested Capital (ROIC) | -49.84% |
Return on Capital Employed (ROCE) | -95.03% |
Revenue Per Employee | $247,119 |
Profits Per Employee | -$237,865 |
Employee Count | 260 |
Asset Turnover | 0.67 |
Inventory Turnover | 1.41 |
Taxes
In the past 12 months, AVITA Medical has paid $54,000 in taxes.
Income Tax | 54,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.22% in the last 52 weeks. The beta is 1.57, so AVITA Medical's price volatility has been higher than the market average.
Beta (5Y) | 1.57 |
52-Week Price Change | -49.22% |
50-Day Moving Average | 9.07 |
200-Day Moving Average | 10.08 |
Relative Strength Index (RSI) | 39.91 |
Average Volume (20 Days) | 206,299 |
Short Selling Information
Short Interest | 2.35M |
Short Previous Month | 1.73M |
Short % of Shares Out | 8.98% |
Short % of Float | n/a |
Short Ratio (days to cover) | 8.91 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $64.25 million and -$61.85 million in losses. Loss per share was -$2.39.
Revenue | 64.25M |
Gross Profit | 55.16M |
Operating Income | -56.59M |
Pretax Income | -49.74M |
Net Income | -61.85M |
EBITDA | -55.47M |
EBIT | -56.59M |
Loss Per Share | -$2.39 |
Full Income Statement Balance Sheet
The company has $35.89 million in cash and $45.99 million in debt, giving a net cash position of -$10.10 million or -$0.38 per share.
Cash & Cash Equivalents | 35.89M |
Total Debt | 45.99M |
Net Cash | -10.10M |
Net Cash Per Share | -$0.38 |
Equity (Book Value) | 4.50M |
Book Value Per Share | 0.17 |
Working Capital | 36.84M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$48.94 million and capital expenditures -$9.17 million, giving a free cash flow of -$58.11 million.
Operating Cash Flow | -48.94M |
Capital Expenditures | -9.17M |
Free Cash Flow | -58.11M |
FCF Per Share | -$2.20 |
Full Cash Flow Statement Margins
Gross margin is 85.85%, with operating and profit margins of -88.08% and -96.26%.
Gross Margin | 85.85% |
Operating Margin | -88.08% |
Pretax Margin | -96.17% |
Profit Margin | -96.26% |
EBITDA Margin | -86.33% |
EBIT Margin | -88.08% |
FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.18% |
Shareholder Yield | n/a |
Earnings Yield | -28.83% |
FCF Yield | -27.08% |
Analyst Forecast
The average price target for AVITA Medical is $17.25, which is 115.09% higher than the current price. The consensus rating is "Buy".
Price Target | $17.25 |
Price Target Difference | 115.09% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 41.57% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 0.2:1.
Last Split Date | Jun 30, 2020 |
Split Type | Reverse |
Split Ratio | 0.2:1 |
Scores
AVITA Medical has an Altman Z-Score of -4.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.89 |
Piotroski F-Score | 3 |